Smith, Maia P · Journal of clinical epidemiology · 2022 · DOI
This study looked at the total health impact of COVID-19 by measuring not just deaths, but also the years of healthy life lost due to long-COVID symptoms. The researchers found that most of the burden from COVID-19 actually comes from people who survive but live with ongoing disability—not from deaths alone. The study suggests that resources should focus on preventing and treating long-COVID, especially in younger people and women who appear to bear a larger share of this burden.
This work is crucial for ME/CFS patients because it establishes that long-COVID—which resembles chronic fatigue syndrome—represents a major public health burden comparable to or exceeding acute mortality. By quantifying disability burden in survivors, the study provides a framework for justifying resource allocation toward long-COVID research and treatment, areas historically underfunded. For ME/CFS researchers, it demonstrates methodologically how to measure and communicate the true disease burden of post-infectious conditions.
This study does not prove the actual incidence or prevalence of long-COVID in real-world populations, as it relies on modeled scenarios rather than empirical epidemiological data. It does not establish causation between COVID-19 and long-COVID outcomes, nor does it identify specific mechanisms or risk factors that determine who develops disabling long-COVID. The model outputs are highly sensitive to underlying assumptions about symptom duration and severity, which remain uncertain.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →